Just as we are celebrating the option of Tecfidera for our MS treatment, doubt creeps in. The
headlines late yesterday had the news that Fumaderm, an earlier form of a drug that has been approved for MS - Tecfidera, formerly known as BG-12- has been possibly linked to four cases of PML in psoriasis patients. I'm sure there will be plenty of headlines for this story - here are the links for the view from MedPage and the other from the financial sector-
http://tinyurl.